Caplin Point Laboratories has announced the availability of the official transcript for its recent earnings call concerning the financial results of the third quarter and the nine months ended December 31, 2025. The call took place on Thursday, February 5, 2026. In compliance with disclosure requirements, the full transcript has been uploaded to the company’s official website for analysts and investors to review performance details.
Disclosure of Earnings Call Transcript
Caplin Point Laboratories Limited has formally communicated the release of the transcript from its recent earnings conference call. This release is made in continuation of the company’s earlier communication dated January 29, 2026.
Financial Period Covered
The transcript pertains to the detailed discussion of the company’s financial performance covering:
- The quarter ended December 31, 2025.
- The nine months ended December 31, 2025.
Availability for Stakeholders
The earnings call itself was held on Thursday, February 5, 2026. The comprehensive document detailing the discussions with analysts and investors is now accessible to the public. Stakeholders can access the transcript directly on the Company’s official website at the following dedicated link: https://www.caplinpoint.net/wp-content/uploads/2025/08/Transcript Q3 FY26.pdf.
The management confirms that this documentation has been placed on record with both the BSE Limited (Scrip Code: 524742) and the National Stock Exchange of India Ltd. (Scrip Code: CAPLIPOINT).
Source: BSE
